Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

412.50p

Change Today:

-6.00p
52 Week High: 445.00
52 Week Low: 166.80

Currency: UK Pounds
Shares Issued: 105.92m
Volume: 253,122

Market Cap: £436.93m
RiskGrade: 125
Beta: 1.23

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart (14-11-2024)

6 Month Chart

More Oxford Biomedica charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-205.7%	-31.8%
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	4.9	3.4
Pr/Book	5.6

	Latest	F'cast
Revenue	-36.0%	45.0%
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

OXB Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-19	64.06	(20.89)	(22.10)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	87.73	(6.57)	(7.81)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	142.80	19.88	22.77p	54.0	n/a	n/a	n/a	0.0%
31-Dec-22	139.99	(45.98)	(41.29)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	89.54	(188.53)	(163.11)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-24	129.82	(41.34)	(41.08)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-25	167.18	(18.44)	(25.85)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-26	211.33	6.16	(3.85)p	n/a	n/a	n/a	n/a	0.0%

Oxford Biomedica forecasts

OXB Company Announcements

Grant of options	05-Nov-2024	14:23	RNS
Holding(s) in Company	04-Nov-2024	10:56	RNS
Total Voting Rights	01-Nov-2024	07:00	RNS

More Oxford Biomedica oxb company announcements

OXB ShareCast News

Oxford Biomedica reports first-half revenue growth	23-Sep-2024	ShareCast
Oxford Biomedica still expecting small loss afte...	08-Aug-2024	ShareCast
Oxford Biomedica appoints new finance chief	17-Jul-2024	ShareCast

More Oxford Biomedica ShareCast news

OXB Top Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ...	16-Aug-2008	Times
Need to know	10-May-2008	Times
DSG International may be losing its spark	12-Feb-2008	Telegraph

Latest OXB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

OXB Market Data

Currency	UK Pounds
Share Price	412.50p
Change Today	-6.00p
% Change	-1.43 %
52 Week High	445.00
52 Week Low	166.80
Volume	253,122
Shares Issued	105.92m
Market Cap	£436.93m
Beta	1.23
RiskGrade	125